4.0 Article

A urological challenge: Voiding dysfunction in multiple sclerosis

期刊

CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL
卷 7, 期 9-10, 页码 S181-S182

出版社

CANADIAN UROLOGICAL ASSOCIATION
DOI: 10.5489/cuaj.1618

关键词

-

资金

  1. Astellas Pharma Canada, Inc.
  2. Allergan
  3. Astellas
  4. AstraZeneca
  5. Paladin

向作者/读者索取更多资源

Patients with multiple sclerosis (MS) have a very high prevalence of lower urinary tract symptoms. This summary provides a brief overview of MS epidemiology, pathophysiology, the impact of the disease on patient quality of life, and the particular kinds of urinary tract abnormalities and symptoms that can present among patients with MS. Strategies to help diminish the impact of these symptoms are also discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据